| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/05/2008 | US7408040 Antibodies to PDGF-D |
| 08/05/2008 | US7408033 PRO5995 polypeptides |
| 08/05/2008 | US7408032 PRO polypeptides; fused to heterologous polypeptide sequences |
| 08/05/2008 | US7408031 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes |
| 08/05/2008 | US7408029 Tyrosine phosphatase peptides for diagnosis, prevention and treatment of autoimmune diseases; immunotherapy |
| 08/05/2008 | US7408028 Peptides, antibodies thereto, and their use in treatment of central nervous system, damage |
| 08/05/2008 | US7408027 Epitopes of the tau protein which are specifically occurring in a phosphorylated state in tau protein from Alzheimer paired helical filaments; for the generation of antibodies specifically detecting Alzheimer tau protein; for testing drugs effective in dissolving Alzheimer paired helical filaments |
| 08/05/2008 | US7408025 Bactericides; peptide antibiotic |
| 08/05/2008 | US7408024 Somatostatin antagonists |
| 08/05/2008 | US7408021 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/05/2008 | US7407986 Administering a isothiocyanate, such as sulforaphane, or a glucosinolate; retinal degeneration, Alzheimer's Disease, and aging |
| 08/05/2008 | US7407982 Polyoxyethylene glycol conjugates mean the drug is eliminated almost completely through the kidneys; bioavailability; anticoagulants |
| 08/05/2008 | US7407947 liposomes containing a sterol skeleton based compound wherein one or several amphoteric groups with an isoelectric point of between 4 and 9 are substituted on the 3rd position of the ring system |
| 08/05/2008 | US7407945 Use of sulfated glycosaminoglycans for establishing effective labor in women |
| 08/05/2008 | US7407944 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| 08/05/2008 | US7407943 Comprises oligonucleotide which targets apolipoprotein nucleotide sequences and prevents expression; gene expresion inhibition; diagnosis and treatment of cardiovascular, infectious, hyperlipidemic and atherosclerotic disorders |
| 08/05/2008 | US7407940 Antimicrobial hexapeptides |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407938 1,4-Diphenyl-3-(3-hydroxy-3-phenylpropyl)-2-azetidinones, e.g., 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-y]lbenzylcarbamoyl}phenoxy)benzoic acid; antilipemic agents that have intestinal absorption of less than 10%, |
| 08/05/2008 | US7407937 Mixture with a cyclic 3', 5'-adenylic acid modulator such as forskolin, activators of adenylate cyclase or macrophages, macrophage-derived factors that stimulate cAMP, calcium ionophores, inhibitors of phosphodiesterase or beta-2-adrenoreceptor or vasoactive intestinal peptide; optional axogenic factor |
| 08/05/2008 | US7407936 Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy |
| 08/05/2008 | US7407935 Ricin toxin A-chain fragment for use as a vaccine |
| 08/05/2008 | US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying |
| 08/05/2008 | US7407933 Containing a mutant angiotensin-converting enzyme that releases glycosylphosphatidylinositol-anchored protein from cell surfaces; for treating a prion-related disease, a bacterial infectious disease or male infertility due to sperm-egg binding insufficiency |
| 08/05/2008 | US7407932 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 08/05/2008 | US7407931 Administering an hematopoietic colony stimulating factors of sargramostim; Crohn's Disease |
| 08/05/2008 | US7407929 Leptin peptide antagonists |
| 08/05/2008 | US7407807 Chimaeric human papillomavirus 16 I1 virus like particles and a method for preparing the particles |
| 08/05/2008 | US7407801 Nucleic acid encoding CFTR (cystic fibrosis transmembrane conductance regulator) protein of cytomegalovirus (CMV); gene therapy for genetic and metabolic disorders; expression in adenoviral-infected nasal epithelium |
| 08/05/2008 | US7407789 Polymerizing ability and cellular and humoral immunogenicity decreased as compared with the wild the wild-type staphylokinase; Mutant genes were constructed by PCR site-directed mutagenesis, then recombined with a prokaryotic vector and used to transform E. coli.; thrombolytics and anticoagulant |
| 08/05/2008 | US7407786 Lipase genes |
| 08/05/2008 | US7407785 Human DNase I hyperactive variants |
| 08/05/2008 | US7407777 IL-2 transmembrane construct |
| 08/05/2008 | US7407771 modulation of apoptosis or inflammatory processes, by transfection of cells with nucleotide sequences that code for proteins, fragments or isoforms capable of binding to or interacting directly or indirectly with death domains and/or binding proteins |
| 08/05/2008 | US7407767 Treating dilated cardiomyopathy by removing anti-cardiac troponin autoantibody from patient's blood |
| 08/05/2008 | US7407751 Methods for the detection and prognosis of breast tumors |
| 08/05/2008 | US7407669 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 08/05/2008 | US7407661 Methods and reagents that generate a CD8 T cell immune response |
| 08/05/2008 | US7407660 Methods and compositions for selective modulation of vascularization |
| 08/05/2008 | US7407659 Methods of diagnosing pre-eclampsia or eclampsia |
| 08/05/2008 | US7407657 Of given sequence; derived from Japanese cypress pollen allergen; stimulates lymphocytes; reduce symptoms of pollinosis; immunotherapy and diagnosis |
| 08/05/2008 | US7407656 PSCA: prostate stem cell antigen and uses thereof |
| 08/05/2008 | US7407655 Method of inhibiting leukocytes with human CXC chemokine receptor 3 antibody |
| 08/05/2008 | US7407653 Treatment of IgA1 deposition diseases |
| 08/05/2008 | US7407651 IFN-β liquid formulations |
| 08/05/2008 | US7407475 Modified annexin proteins, and methods and compositions for using them |
| 08/05/2008 | CA2380902C Process to make a sustained release formulation |
| 08/05/2008 | CA2343575C Inhibition of smooth muscle cell migration by heme oxygenase 1 |
| 08/05/2008 | CA2340888C Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
| 08/05/2008 | CA2290485C Method for the production of non-immunogenic proteins |
| 08/05/2008 | CA2259640C Human glycine transporter |
| 08/05/2008 | CA2246715C Antibody variants |
| 08/05/2008 | CA2226457C Oligonucleotides specific for human papilloma virus |
| 08/05/2008 | CA2167087C Peptides for neutralizing the toxicity of lipid a |
| 08/05/2008 | CA2163989C Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| 08/05/2008 | CA2161808C Bmp-11 compositions |
| 08/05/2008 | CA2137378C D-enzyme compositions and methods of their use |
| 08/05/2008 | CA2113243C Pharmaceutical compositions containing nanocapsules |
| 08/05/2008 | CA2111199C Pharmaceutical formulations of osteogenic proteins |
| 07/31/2008 | WO2008092084A2 Injectable non-aqueous suspension with high concentration of therapeutic agent |
| 07/31/2008 | WO2008091925A2 Treatment of aortic dissection or aneurysm |
| 07/31/2008 | WO2008091763A1 Treating hepatitis c virus infection |
| 07/31/2008 | WO2008091710A2 Methods and compositions for treating neuropathies |
| 07/31/2008 | WO2008091692A2 Methods of diagnosing, treating, and preventing increased vascular permeability |
| 07/31/2008 | WO2008091655A2 Methods, compositions and device for directed and controlled heating and release of agents |
| 07/31/2008 | WO2008091643A2 Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy |
| 07/31/2008 | WO2008091632A2 A peptide composition and a method of promoting cartilage formation |
| 07/31/2008 | WO2008091620A2 Combination therapy comprising romidepsin and i.a. bortezomib |
| 07/31/2008 | WO2008091408A2 Circulating renalase and methods of increasing same |
| 07/31/2008 | WO2008091349A1 Bifunctional histone deacetylase inhibitors |
| 07/31/2008 | WO2008091177A1 Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
| 07/31/2008 | WO2008091043A1 A composition for prevention or treatment of bone marrow damage |
| 07/31/2008 | WO2008090831A1 Enzyme composition and use thereof |
| 07/31/2008 | WO2008090678A1 Novel peptide |
| 07/31/2008 | WO2008090534A1 Methods and compositions for inhibition of excessive weight gain, reduction of inappropriate eating behaviours and inhibition of binge eating for the treatment of obesity |
| 07/31/2008 | WO2008090360A1 Methods |
| 07/31/2008 | WO2008090287A2 Use of at least one botulism neurotoxin for treating the pain induced by therapeutic treatments for the aids virus |
| 07/31/2008 | WO2008090224A1 Method for inducing thrombopoiesis |
| 07/31/2008 | WO2008090217A1 Purification of fc-tact fusion proteins using the oilbody technology |
| 07/31/2008 | WO2008090215A1 Factor vii polypeptides with increased affinity to platelets |
| 07/31/2008 | WO2008090174A1 New anti-malaria vaccine compositions and uses thereof |
| 07/31/2008 | WO2008089987A1 Use of gdf-5 for the improvement or maintenance of dermal appearance |
| 07/31/2008 | WO2008089645A1 Fusion polypeptide inhibiting cell growth and use thereof |
| 07/31/2008 | WO2008089602A1 The tetracyclic anthraquinones possessing anti-cancer effect |
| 07/31/2008 | WO2008089532A1 Pharmaceutical compositions and methods for treating erectile dysfunction |
| 07/31/2008 | WO2008073957A3 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 07/31/2008 | WO2008073466A3 Alpha b-crystallin as a therapy for inflammation |
| 07/31/2008 | WO2008070859A3 Treatment of skin conditions by dickkopf1 (dkk1) |
| 07/31/2008 | WO2008068621A3 Combination product with ido inhibitor and tumor targeted ifn-gamma |
| 07/31/2008 | WO2008067532A3 Antagonists of pge2 ep3 receptors |
| 07/31/2008 | WO2008067234A3 Use of anti-cytokine agents for treating carpal and tarsal tunnel syndrome |
| 07/31/2008 | WO2008065387A3 Potentiation of erythropoietin (epo) action by membrane steroid receptor agonists |
| 07/31/2008 | WO2008063639A3 Compositions and methods for preserving cells of the eye |
| 07/31/2008 | WO2008057875A3 Inhibitors of hepatitis c virus |
| 07/31/2008 | WO2008055711A3 Use of an adenosine antagonist |
| 07/31/2008 | WO2008055626A8 Protein-containing substance with increased thermal stability |
| 07/31/2008 | WO2008055145A9 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 07/31/2008 | WO2008041014A3 Interferon- alpha constructs for use in the treatment of diseases characterised by abnormal cell proliferation such as cancer |
| 07/31/2008 | WO2008031092A9 Immunostimulatory composition comprising lipoprotein in microalgae extract |
| 07/31/2008 | WO2008025033A3 Use of il-27 antagonists for the manufacture of a medicament for the treatment of aplastic anemia |